Abstract
At the dawn of the new millennium, we have seen a vigorous clinical response to the changing and challenging problems of otitis media, with a high prevalence, greater bacterial resistance, and even greater educational and occupational impact than previously realized. New medical and surgical treatments and a better understanding of host-disease factors, including genetic and molecular investigations, may emerge from this productive year’s work. This update summarizes the latest epidemiologic and basic science studies, new medications, management of multidrug resistance by changing indications for antibiotic use and dosing regimens, the new pneumococcal vaccine, and the role of laser myringotomy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Current Opinion in Otolaryngology & Head and Neck Surgery
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
